Puma Biotechnology Inc
NASDAQ:PBYI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
PBYI
is 3.57 USD
with a low forecast of 2.02 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PBYI's stock price target?
Price Target
3.57
USD
According to Wall Street analysts, the average 1-year price target for
PBYI
is 3.57 USD
with a low forecast of 2.02 USD and a high forecast of 5.25 USD.
What is Puma Biotechnology Inc's Revenue forecast?
Projected CAGR
-1%
The
compound annual growth rate
of Puma Biotechnology Inc's revenue for the next 4 years is
-1%.
What is Puma Biotechnology Inc's Operating Income forecast?
Projected CAGR
-5%
The
compound annual growth rate
of Puma Biotechnology Inc's operating income for the next 4 years is
-5%.
What is Puma Biotechnology Inc's Net Income forecast?
Projected CAGR
-1%
The
compound annual growth rate
of Puma Biotechnology Inc's net income for the next 4 years is
-1%.
